North America Automated and Closed Cell Therapy Processing Systems Market By type (stem cell therapy, and non-stem cell therapy), By workflow (separation, expansion, apheresis, fill-finish, cryopreservation and others), By scale (Pre-commercial/R&D Scale and Commercial Scale), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America Automated and Closed Cell Therapy Processing Systems Market
Market Report Description
The North America Automated And Closed Cell Therapy Processing Systems Market would witness market growth of 19.6% CAGR during the forecast period (2021-2027).
Automated process system as a sustainable strategy to boost their cell therapy product development procedure, which would propel the growth of the market. There has been an increase in clinical trials regarding advanced therapies in the past few years, which is estimated to surge the demand for advanced & automated technologies to get high yield and throughput.
The strong healthcare sector of developed nations like the US and Canada is estimated to support the growth of the regional market. In addition, the high adoption of various advanced systems, therapies, and solutions in the regional healthcare sector is estimated to support the growth of the regional automated and closed cell therapy processing system market in the upcoming years. Along with that, the growing popularity of regenerative medicines and stem cell therapies would accelerate the growth of the regional market over the forecast period.
The US market dominated the North America Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $709.8 million by 2027. The Canada market is estimated to grow a CAGR of 22.3% during (2021 - 2027). Additionally, The Mexico market would showcase a CAGR of 21.2% during (2021 - 2027).
Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
- Stem Cell Therapy
- Non-Stem Cell Therapy
- Pre-commercial/R&D Scale
- Commercial Scale
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free